Insider trades
Duncan McKechnie, Chief Officer of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $4.9M. The latest trade was on 03/11.
Duncan McKechnie
EVP, Chief Commercial Officer
- Company
- Vertex Pharmaceuticals VRTX
- First filing
- 26/03/13
- Trades
- 11 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- −$4.9M
- Last trade
- 03/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/11 | 03/13 | 2,633 sh | $498.42 | $1,312,339.86 | −17.4% | |
| Open-market sale10b5-1 plan | 03/04 | 03/06 | 2,437 sh | $475.30 | $1,158,306.1 | −13.9% | |
VRTX | Open-market sale10b5-1 plan | 02/25 | 02/26 | 4,910 sh2 trades | $487.65avg. | $2,394,365 | −21.9% |